Surgically-Induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome

Objective:To evaluate the effects of surgical weight loss on fatty liver disease in severely obese patients. Summary Background Data:Nonalcoholic fatty liver disease (NAFLD), a spectrum that extends to liver fibrosis and cirrhosis, is rising at an alarming rate. This increase is occurring in conjunction with the rise of severe obesity and is probably mediated in part by metabolic syndrome (MS). Surgical weight loss operations, probably by reversing MS, have been shown to result in improvement in liver histology. Methods:Patients who underwent laparoscopic surgical weight loss operations from March 1999 through August 2004, and who agreed to have an intraoperative liver biopsy followed by at least one postoperative liver biopsy, were included. Results:There were 70 patients who were eligible. All patients underwent laparoscopic operations, the majority being laparoscopic Roux-en-Y gastric bypass. The mean excess body weight loss at time of second biopsy was 59% ± 22% and the time interval between biopsies was 15 ± 9 months. There was a reduction in prevalence of metabolic syndrome, from 70% to 14% (P < 0.001), and a marked improvement in liver steatosis (from 88% to 8%), inflammation (from 23% to 2%), and fibrosis (from 31% to 13%; all P < 0.001). Inflammation and fibrosis resolved in 37% and 20% of patients, respectively, corresponding to improvement of 82% (P < 0.001) in grade and 39% (P < 0.001) in stage of liver disease. Conclusion:Surgical weight loss results in significant improvement of liver morphology in severely obese patients. These beneficial changes may be associated with a significant reduction in the prevalence of the metabolic syndrome.

[1]  C. Frantzides,et al.  Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery , 2004, Journal of Gastrointestinal Surgery.

[2]  A. Sanyal,et al.  Clinical aspects of fatty liver disease. , 2004, Seminars in liver disease.

[3]  E. Mun,et al.  Effects of weight loss surgeries on liver disease. , 2004, Seminars in liver disease.

[4]  Alison Hoppin1.  Obesity and the Liver: Developmental Perspectives , 2004, Seminars in liver disease.

[5]  E. Fassio,et al.  Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies , 2004, Hepatology.

[6]  D. Helinski,et al.  A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients , 2004, Alimentary pharmacology & therapeutics.

[7]  N. Chalasani,et al.  Nonalcoholic fatty liver disease in individuals with severe obesity. , 2004, Clinics in liver disease.

[8]  J. Dixon,et al.  Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss , 2004, Hepatology.

[9]  L. Burgart,et al.  Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial , 2004, Hepatology.

[10]  N. Punjabi,et al.  Sleep-disordered breathing, glucose intolerance, and insulin resistance , 2003, Respiratory Physiology & Neurobiology.

[11]  P. Schauer.  Open and laparoscopic surgical modalities for the management of obesity , 2003, Journal of Gastrointestinal Surgery.

[12]  N. Chalasani,et al.  Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis , 2003, Hepatology.

[13]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[14]  P. Schauer,et al.  Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity , 2000, Annals of surgery.

[15]  P. Kopelman.  Obesity as a medical problem , 2000, Nature.

[16]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[17]  A. Scheen,et al.  Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty , 1998, International Journal of Obesity.

[18]  F. Brunetti,et al.  Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population) , 1997, Digestive Diseases and Sciences.

[19]  G. Gores,et al.  Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study , 1996, Hepatology.

[20]  H. Appelman,et al.  Regression of hepatic steatosis in morbidly obese persons after gastric bypass. , 1995, American journal of clinical pathology.

[21]  G. Dohm,et al.  Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. , 1992, The American journal of clinical nutrition.

[22]  S. Thung,et al.  Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. , 2004, Surgery.

[23]  P. Schauer,et al.  Results of Laparoscopic Gastric Bypass in Patients with Cirrhosis , 2004, Obesity surgery.

[24]  P. Schauer,et al.  Laparoscopic gastric bypass surgery: current technique. , 2003, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[25]  P. O’Brien,et al.  Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity , 1999, The British journal of surgery.

[26]  R. Varco,et al.  Liver biopsy findings in seventy-seven consecutive patients undergoing jejunoileal bypass for morbid obesity. , 1974, American journal of surgery.